NCT00460083View on ClinicalTrials.gov

Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis

PHASE4CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

February 29, 2008

Conditions
Atopic Dermatitis
Interventions
DRUG

Elidel(R) (pimecrolimus 1%)

DEVICE

EpiCeram(R) -ceramide based barrier repair cream

Trial Locations (2)

Unknown

UCSD, San Diego

OHSU, Portland

Sponsors
All Listed Sponsors
lead

Ceragenix Pharmaceuticals

INDUSTRY